1h Free Analyst Time
The contrast media market is forecasted to grow by USD 925.1 million during 2023-2028, accelerating at a CAGR of 3.2% during the forecast period. The report on the contrast media market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing geriatric population and chronic and infectious diseases, rise in healthcare spending, and approval of new contrast media.
The contrast media market is segmented as below:
By Modality
- X-ray/CT
- MRI
- Ultrasound
By Application
- Neurological disorders
- Cardiovascular disorders
- Cancer
- Gastrointestinal disorders
- Others
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the contrast media market covers the following areas:
- Contrast media market sizing
- Contrast media market forecast
- Contrast media market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Modality
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global contrast media market: Bayer AG, Beijing Beilu Pharmaceutical Co. Ltd., Blue Jet Healthcare Ltd., Bracco Spa, Covis Pharma GmbH, GE Healthcare Technologies Inc., Guerbet, iMAX Diagnostic Imaging Ltd., Interpharma Praha as, J. B. Chemicals and Pharmaceuticals Ltd, Jodas Expoim Pvt. Ltd., Lantheus Holdings Inc., Livealth Biopharma Pvt. Ltd., M.Biotech Ltd., Nano Therapeutics Pvt. Ltd., Novalek Pharmaceuticals Pvt Ltd., SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Taejoon Pharm Co. Ltd., and Unijules Life Sciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is launch of new contrast media."
According to the report, one of the major drivers for this market is the increasing geriatric population and chronic and infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- Beijing Beilu Pharmaceutical Co. Ltd.
- Blue Jet Healthcare Ltd.
- Bracco Spa
- Covis Pharma GmbH
- GE Healthcare Technologies Inc.
- Guerbet
- iMAX Diagnostic Imaging Ltd.
- Interpharma Praha as
- J. B. Chemicals and Pharmaceuticals Ltd
- Jodas Expoim Pvt. Ltd.
- Lantheus Holdings Inc.
- Livealth Biopharma Pvt. Ltd.
- M.Biotech Ltd.
- Nano Therapeutics Pvt. Ltd.
- Novalek Pharmaceuticals Pvt Ltd.
- SANOCHEMIA Pharmazeutika GmbH
- Spago Nanomedical AB
- Taejoon Pharm Co. Ltd.
- Unijules Life Sciences Ltd.
